Covered recipient · General Payments record
ANITA RACHEL CELA
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2019–2025
$2,216.51
- Reported across 86 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $466.75 | 16 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $278.19 | 9 |
| Galderma Laboratories, L.P. | $72.85 | 3 |
| MAYNE PHARMA COMMERCIAL LLC | $32.72 | 1 |
| Mallinckrodt Hospital Products Inc. | $32.66 | 1 |
| Regeneron Healthcare Solutions, Inc. | $28.81 | 1 |
| Janssen Biotech, Inc. | $21.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.43 | 01/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201621790 | CMS |
| ABBVIE INC. | $31.15 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201621792 | CMS |
| ABBVIE INC. | $34.13 | 05/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201621794 | CMS |
| ABBVIE INC. | $34.56 | 06/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201621796 | CMS |
| ABBVIE INC. | $30.31 | 07/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201621798 | CMS |
| ABBVIE INC. | $33.57 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201621800 | CMS |
| ABBVIE INC. | $30.95 | 09/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201621802 | CMS |
| ABBVIE INC. | $20.09 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201621804 | CMS |
| ABBVIE INC. | $31.00 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201621806 | CMS |
| Galderma Laboratories, L.P. | $28.60 | 01/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234626028 | CMS |
| Galderma Laboratories, L.P. | $19.58 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234626030 | CMS |
| Galderma Laboratories, L.P. | $24.67 | 08/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234626032 | CMS |
| Janssen Biotech, Inc. | $21.52 | 09/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175407946 | CMS |
| Mallinckrodt Hospital Products Inc. | $32.66 | 05/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1211956622 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $32.72 | 08/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1254351859 | CMS |
| Regeneron Healthcare Solutions, Inc. | $28.81 | 07/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1212885466 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.